113 related articles for article (PubMed ID: 17438058)
1. Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection.
Doh-Ura K; Kuge T; Uomoto M; Nishizawa K; Kawasaki Y; Iha M
Antimicrob Agents Chemother; 2007 Jun; 51(6):2274-7. PubMed ID: 17438058
[TBL] [Abstract][Full Text] [Related]
2. Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.
Kovalchuk Ben-Zaken O; Nissan I; Tzaban S; Taraboulos A; Zcharia E; Matzger S; Shafat I; Vlodavsky I; Tal Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):698-704. PubMed ID: 26168721
[TBL] [Abstract][Full Text] [Related]
3. In vitro anticancer activity of fucoidan from Turbinaria conoides against A549 cell lines.
Marudhupandi T; Ajith Kumar TT; Lakshmanasenthil S; Suja G; Vinothkumar T
Int J Biol Macromol; 2015 Jan; 72():919-23. PubMed ID: 25451746
[TBL] [Abstract][Full Text] [Related]
4. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent.
Schwarz A; Krätke O; Burwinkel M; Riemer C; Schultz J; Henklein P; Bamme T; Baier M
Neurosci Lett; 2003 Oct; 350(3):187-9. PubMed ID: 14550926
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology and genetics of prion diseases.
Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
[TBL] [Abstract][Full Text] [Related]
6. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
7. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay.
Solassol J; Arlotto M; Lehmann S
J Hosp Infect; 2004 Jun; 57(2):156-61. PubMed ID: 15183247
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of gastric acid secretion increase the risk of prion infection in mice.
Martinsen TC; Benestad SL; Moldal T; Waldum HL
Scand J Gastroenterol; 2011 Dec; 46(12):1418-22. PubMed ID: 21936725
[TBL] [Abstract][Full Text] [Related]
9. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
Matsumoto S; Nagaoka M; Hara T; Kimura-Takagi I; Mistuyama K; Ueyama S
Clin Exp Immunol; 2004 Jun; 136(3):432-9. PubMed ID: 15147344
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
12. Enhanced enteric invasion of scrapie agents into the villous columnar epithelium via maternal immunoglobulin.
Ano Y; Sakudo A; Uraki R; Sato Y; Kono J; Sugiura K; Yokoyama T; Itohara S; Nakayama H; Yukawa M; Onodera T
Int J Mol Med; 2010 Dec; 26(6):845-51. PubMed ID: 21042778
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PrPSc formation by synthetic O-sulfated glycopyranosides and their polymers.
Yamaguchi S; Nishida Y; Sasaki K; Kambara M; Kim CL; Ishiguro N; Nagatsuka T; Uzawa H; Horiuchi M
Biochem Biophys Res Commun; 2006 Oct; 349(2):485-91. PubMed ID: 16949037
[TBL] [Abstract][Full Text] [Related]
14. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
[TBL] [Abstract][Full Text] [Related]
15. BSE: can we predict the future?
Plum J
Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
[TBL] [Abstract][Full Text] [Related]
16. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.
Priola SA; Caughey B; Raymond GJ; Chesebro B
Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
18. Antiprion properties of prion protein-derived cell-penetrating peptides.
Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
[TBL] [Abstract][Full Text] [Related]
19. Excretion of BSE and scrapie prions in stools from murine models.
Maluquer de Motes C; Grassi J; Simon S; Herva ME; Torres JM; Pumarola M; Girones R
Vet Microbiol; 2008 Sep; 131(1-2):205-11. PubMed ID: 18395370
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of scrapie prion protein in soil.
Nagaoka K; Yoshioka M; Shimozaki N; Yamamura T; Murayama Y; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2010 Jul; 397(3):626-30. PubMed ID: 20570651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
